A Multicenter Phase 1b Randomized, Placebo-controlled, Blinded Study to Evaluate the Safety, Tolerability and Efficacy of Microbiome Study Intervention Administration in Combination With Anti-PD-1 Therapy in Adult Patients With Unresectable or Metastatic Melanoma
Latest Information Update: 10 Jun 2024
At a glance
Most Recent Events
- 04 Apr 2024 Study design of this trial described in an abstract published in 115th Annual Meeting of the American Association for Cancer Research.
- 07 Jun 2022 Status changed from discontinued to completed.
- 11 May 2022 Planned End Date changed from 1 Mar 2023 to 1 Sep 2022.